GlassScriptPhysician profile
Kwadwo O Boadi
NPI 1215946363
$2,495.47
in general payments reported to CMS, 2019-2025
16 companies · $259 in 2025
The $259 reported for 2025 was more than what 85% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $395 · 2020: $498 · 2021: $410 · 2022: $358 · 2023: $306 · 2024: $269 · 2025: $259.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $834.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $834.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $788.78 | 2019-2025 | Skyrizi, Rinvoq |
| Intercept Pharmaceuticals, INC. | $385.28 | 2019-2025 | Ocaliva |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $260.16 | 2019-2024 | Trulance |
| Gilead Sciences, INC. | $239.62 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $183.24 | 2021-2025 | Entyvio |
| Janssen Biotech, INC. | $177.85 | 2019-2023 | Simponi, Simponi Aria, Remicade |
| Qol Medical, LLC | $108.77 | 2022-2025 | Sucraid, Sucraid |
| Braintree Laboratories, INC. | $70.14 | 2019-2024 | Sutab, Suflave |
| Ardelyx, INC. | $64.28 | 2025 | Ibsrela |
| Phathom Pharmaceuticals, INC. | $49.94 | 2023-2024 | Voquezna |
| Redhill Biopharma INC. | $46.40 | 2021 | |
| Cumberland Pharmaceuticals, INC. | $42.62 | 2019-2020 | |
| Ipsen Biopharmaceuticals, INC | $24.18 | 2024 | Iqirvo |
| Novo Nordisk INC | $19.08 | 2025 | Wegovy |
| Romark Laboratories, Lc | $17.74 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironwood Pharmaceuticals, INC | $17.39 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kwadwo Boadi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.